Additional immunostaining for vascular endothelial growth factor (rabbit anti-VEGF, RB-9031-R7, Thermo Scientific, USA) showed that VEGF-positive cancer cells occupied the majority of the sites of both the primary tumor and the tumor emboli in the pulmonary arterioles (Fig. 4). This evidence concerns the gene VEGFA and neoplasm.